WIPO
open access
CC BY-NC 4.0
Introduction to Regulatory Affairs and Different Regulatory Bodies for Pharmaceutical Products and Impact of Digitalization on Regulatory Affairs
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Ethical, legal, and social implications of AI-enabled digital therapeutics: A comparative analysis of risk-based regulatory frameworks in the European Union and Japan.#135843
- Pharmaceuticals#127278
- Zur Nutzung des digitalisierten wissenschaftlichen Nachlasses von Prof. Dr. Gerold Ungeheuer#646634
- Implications of the Business Strategies of Pharmaceutical Companies for Industry Developments in Australia#1026056
- The Effects of False Claims Act Whistleblowers on the Pharmaceutical Industry#485775
Record · ID 163391
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive